Updates on MDMA-Assisted Psychotherapy for PTSD Studies: Research from Around the World

Researchers deliver updates on MDMA-assisted psychotherapy for treatment-resistant PTSD from study sites in Colorado, Israel, Canada, the UK, and Australia. The presentations cover the specifics of trial designs as well as the unique hurdles and regulatory environments faced by each international team. Key discussions include the logistical challenges of setting up specialized clinical sites, such as finding appropriate facilities and navigating local regulatory frameworks. Furthermore, the speakers contrast the varying social and political climates surrounding psychedelic medicine, noting how public awareness and evolving discourse influence the recruitment process and overall progress of these clinical investigations.